1. Home
  2. SPCB vs ATRA Comparison

SPCB vs ATRA Comparison

Compare SPCB & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$10.37

Market Cap

39.8M

Sector

Technology

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$10.26

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
ATRA
Founded
1988
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8M
38.9M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
SPCB
ATRA
Price
$10.37
$10.26
Analyst Decision
Sell
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
65.0K
109.4K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
122.52
EPS
N/A
N/A
Revenue
N/A
$120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
N/A
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$3.92
52 Week High
$13.57
$19.15

Technical Indicators

Market Signals
Indicator
SPCB
ATRA
Relative Strength Index (RSI) 47.56 57.07
Support Level $9.76 $8.95
Resistance Level $10.86 $11.35
Average True Range (ATR) 0.70 0.81
MACD -0.21 -0.15
Stochastic Oscillator 24.19 35.00

Price Performance

Historical Comparison
SPCB
ATRA

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Share on Social Networks: